Treatment of a Whole Population Sample of Alzheimer’s Disease with Donepezil over a 4-Year Period: Lessons Learned-Reference-Cited by-同舟云学术

Treatment of a Whole Population Sample of Alzheimer’s Disease with Donepezil over a 4-Year Period: Lessons Learned

Published:2008 Issue:3 Volume:25 Page:226-231
ISSN:1420-8008
Container-title:Dementia and Geriatric Cognitive Disorders
language:en
Short-container-title:Dement Geriatr Cogn Disord

Author:

Lyle Sarah,Grizzell Moni,Willmott Sasi,Benbow Susan,Clark Michael,Jolley David

Publisher

S. Karger AG

Subject

Psychiatry and Mental health,Cognitive Neuroscience,Geriatrics and Gerontology

Reference29 articles.

1. Qizilbash N, Schneider L, Chui H, etal: Evidence-Based Dementia Practice. Oxford, Blackwell, 2002.

2. The Effects of Donepezil in Alzheimer’s Disease – Results from a Multinational Trial¹

3. Role of cholinesterase inhibitors in dementia care needs rethinking

4. National Institute of Clinical Excellence: TA111 Alzheimer's disease - donepezil, galantamine, rivastigmine (review) and memantine: guidance. November 17, 2006, www.nice.org.uk/guidance/TA111/guidance/pdf/English.

5. Memory clinics

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Framework of treating Alzheimer’s dementia;Brain Science Advances;2019-06

2. Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer’s disease;Alzheimer's Research & Therapy;2017-03-16

3. Current Medications for the Treatment of Alzheimer’s Disease;Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders;2017

4. Treatment and Management of Dementia Due to Alzheimer’s Disease;Current Treatment Options in Neurology;2015-07-03

5. Effectiveness and Safety of MLC601 in the Treatment of Mild to Moderate Alzheimer's Disease: A Multicenter, Randomized Controlled Trial;Dementia and Geriatric Cognitive Disorders Extra;2015-03-07